The cell free DNA methylome of primary and metastatic prostate tumors

ABSTRACT: Metastatic prostate cancer remains a major clinical challenge. Liquid biopsy is emerging as a promising tool in disease management and provides valuable opportunities to gain insights into the underlying biology. Here, we used the highly sensitive, methylated DNA immunoprecipitation coupled to next generation sequencing (MeDIP) technology, to interrogate the cell-free DNA methylomes across localized and metastatic prostate cancer.

PROVIDER: EGAS00001005522 | EGA |

REPOSITORIES: EGA